Back
Cytokinetics Stock Price Chart

This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
CYTK
Cytokinetics
Last Price:
$40.44
Seasonality Move:
8.2%
7 Day Trial
ALL ACCESS PASS
$
7

Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing slight buying pressure.
Cytokinetics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.96 | Buy |
20-day SMA: | 38.74 | Buy |
50-day SMA: | 42.37 | Sell |
200-day SMA: | 50.15 | Sell |
8-day EMA: | 39.1 | Buy |
20-day EMA: | 36.26 | Buy |
50-day EMA: | 25.58 | Buy |
200-day EMA: | 9.14 | Buy |
Cytokinetics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.58 | Buy |
Relative Strength Index (14 RSI): | 51.03 | Buy |
Chaikin Money Flow: | 409840 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.99 - 42.85) | Buy |
Bollinger Bands (100): | (41.17 - 49.71) | Sell |
Cytokinetics Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cytokinetics Stock
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 40.43 while CYTK 8-day simple moving average is 38.96, which is a Buy signal.
-
The stock price of CYTK is 40.43 while Cytokinetics 20-day SMA is 38.74, which makes it a Buy.
-
Cytokinetics 50-day simple moving average is 42.37 while CYTK share price is 40.43, making it a Sell technically.
-
CYTK stock price is 40.43 and Cytokinetics 200-day simple moving average is 50.15, creating a Sell signal.
CYTK Technical Analysis vs Fundamental Analysis
Sell
34
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy or a Sell?
-
Cytokinetics stock is rated a SellThe current Cytokinetics [CYTK] share price is $40.43. The Score for CYTK is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Cytokinetics Stock Info
Market Cap:
4.8B
Price in USD:
40.43
Share Volume:
893.4K
Cytokinetics 52-Week Range
52-Week High:
68.44
52-Week Low:
32.74
Sell
34
Cytokinetics (CYTK)
is a Sell
Cytokinetics Share Price Forecast
-
What is the Cytokinetics stock price today?The Cytokinetics stock price is 40.43 USD today.
-
Will CYTK stock go up or go down?Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cytokinetics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is overvalued.
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 40.43 while CYTK 8-day exponential moving average is 39.10, which is a Buy signal.
-
The stock price of CYTK is 40.43 while Cytokinetics 20-day EMA is 36.26, which makes it a Buy.
-
Cytokinetics 50-day exponential moving average is 25.58 while CYTK share price is 40.43, making it a Buy technically.
-
CYTK stock price is 40.43 and Cytokinetics 200-day simple moving average is 9.14, creating a Buy signal.
Fundamental Analysis of Cytokinetics
Is Cytokinetics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.48 per share, and an increase next year of $0.69 per share.
Technical Analysis of Cytokinetics
Should I short Cytokinetics stock?
-
CYTK Moving Average Covergence Divergence (MACD) indicator is 4.58, suggesting Cytokinetics is a Buy
-
Cytokinetics Relative Strength Index (RSI) is 51.03, which suggest Cytokinetics is overbought
-
The Bollinger Bands (25) for Cytokinetics is (36.99 - 42.85), which suggest Cytokinetics is a Sell
-
The Bollinger Bands (100) for Cytokinetics is (41.17 - 49.71), which suggest Cytokinetics is a Sell
* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.